Alamar Biosciences, Inc. Common Stock (ALMR)vsBoston Scientific Corp (BSX)
ALMR
Alamar Biosciences, Inc. Common Stock
$25.04
+2.29%
HEALTHCARE · Cap: $1.67B
BSX
Boston Scientific Corp
$57.61
+0.80%
HEALTHCARE · Cap: $85.62B
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 27678% more annual revenue ($20.61B vs $74.21M). BSX leads profitability with a 17.3% profit margin vs -40.2%. BSX earns a higher WallStSmart Score of 71/100 (B).
ALMR
Avoid16
out of 100
Grade: F
BSX
Strong Buy71
out of 100
Grade: B
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for ALMR.
Margin of Safety
-25.1%
Fair Value
$46.04
Current Price
$57.61
$11.57 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Earnings expanding 100.0% YoY
Large-cap with strong market position
Growing faster than its price suggests
Strong operational efficiency at 21.5%
Generating 1.0B in free cash flow
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -33.6% — below average capital efficiency
No major concerns identified
Comparative Analysis Report
WallStSmart ResearchBull Case : ALMR
ALMR has a balanced fundamental profile.
Bull Case : BSX
The strongest argument for BSX centers on EPS Growth, Market Cap, PEG Ratio. Profitability is solid with margins at 17.3% and operating margin at 21.5%. Revenue growth of 11.6% demonstrates continued momentum.
Bear Case : ALMR
The primary concerns for ALMR are Revenue Growth, EPS Growth, Market Cap.
Bear Case : BSX
No major red flags identified for BSX, but monitor valuation.
Key Dynamics to Monitor
ALMR profiles as a turnaround stock while BSX is a mature play — different risk/reward profiles.
BSX is growing revenue faster at 11.6% — sustainability is the question.
BSX generates stronger free cash flow (1.0B), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BSX scores higher overall (71/100 vs 16/100), backed by strong 17.3% margins and 11.6% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?